Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
68
NCLH Quote, Financials, Valuation and Earnings
Last price:
$23.61
Seasonality move
:
0.5%
Day range:
$22.82 - $23.45
52-week range:
$14.21 - $29.29
Dividend yield:
0%
P/E ratio:
13.32x
P/S ratio:
1.22x
P/B ratio:
7.27x
Volume:
17.1M
Avg. volume:
16M
1-year change:
13.16%
Market cap:
$10.3B
Revenue:
$9.5B
EPS (TTM):
$1.73
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | $648M | $4.8B | $8.5B | $9.5B | |
| Revenue Growth (YoY) | -80.2% | -49.37% | 647.51% | 76.51% | 10.87% | |
| Cost of Revenues | $1.7B | $1.6B | $4.3B | $5.5B | $5.7B | |
| Gross Profit | -$413.2M | -$960.1M | $576.7M | $3.1B | $3.8B | |
| Gross Profit Margin | -32.28% | -148.16% | 11.91% | 36.04% | 39.99% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $745.3M | $891.5M | $1.4B | $1.3B | $1.4B | |
| Other Inc / (Exp) | -$1.6B | $124M | $76.6M | -$40.2M | $54.2M | |
| Operating Expenses | $1.5B | $1.6B | $2.1B | $2.2B | $2.3B | |
| Operating Income | -$1.9B | -$2.6B | -$1.6B | $930.9M | $1.5B | |
| Net Interest Expenses | $482.3M | $2.1B | $801.5M | $727.5M | $747.2M | |
| EBT. Incl. Unusual Items | -$4B | -$4.5B | -$2.3B | $163.2M | $772.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $12.5M | $5.3M | -$6.8M | -$3M | -$137.4M | |
| Net Income to Company | -$4B | -$4.5B | -$2.3B | $166.2M | $910.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$4B | -$4.5B | -$2.3B | $166.2M | $910.3M | |
| Basic EPS (Cont. Ops) | -$15.75 | -$12.33 | -$5.41 | $0.39 | $2.09 | |
| Diluted EPS (Cont. Ops) | -$15.75 | -$12.33 | -$5.41 | $0.39 | $1.89 | |
| Weighted Average Basic Share | $254.7M | $365.4M | $419.8M | $424.4M | $435.3M | |
| Weighted Average Diluted Share | $254.7M | $365.4M | $419.8M | $427.4M | $515M | |
| EBITDA | -$2.8B | -$1.7B | -$665.1M | $1.8B | $2.5B | |
| EBIT | -$3.5B | -$2.4B | -$1.5B | $890.7M | $1.5B | |
| Revenue (Reported) | $1.3B | $648M | $4.8B | $8.5B | $9.5B | |
| Operating Income (Reported) | -$1.9B | -$2.6B | -$1.6B | $930.9M | $1.5B | |
| Operating Income (Adjusted) | -$3.5B | -$2.4B | -$1.5B | $890.7M | $1.5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.1M | $521.9M | $1.8B | $2.2B | $2.1B | |
| Revenue Growth (YoY) | -99.75% | 16736.77% | 249.07% | 20.27% | -2.91% | |
| Cost of Revenues | $200.9M | $735.4M | $1.3B | $1.4B | $1.3B | |
| Gross Profit | -$197.8M | -$213.5M | $541.5M | $803.8M | $823.6M | |
| Gross Profit Margin | -6379.19% | -40.9% | 29.72% | 36.68% | 38.71% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $203.2M | $296.2M | $336M | $362.5M | $391.4M | |
| Other Inc / (Exp) | $27.2M | $38.1M | -$9M | $18.1M | -$24.5M | |
| Operating Expenses | $373.5M | $475.3M | $530.8M | $585.4M | $622.7M | |
| Operating Income | -$571.3M | -$688.8M | $10.7M | $218.4M | $200.9M | |
| Net Interest Expenses | $824.4M | $327.7M | $171.3M | $218.2M | $217.9M | |
| EBT. Incl. Unusual Items | -$1.4B | -$978.3M | -$169.5M | $18.4M | -$41.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.7M | $4.4M | -$10.2M | $1M | -$1.1M | |
| Net Income to Company | -$1.4B | -$982.7M | -$159.3M | $17.4M | -$40.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1.4B | -$982.7M | -$159.3M | $17.4M | -$40.3M | |
| Basic EPS (Cont. Ops) | -$4.16 | -$2.35 | -$0.38 | $0.04 | -$0.09 | |
| Diluted EPS (Cont. Ops) | -$4.16 | -$2.35 | -$0.38 | $0.04 | -$0.09 | |
| Weighted Average Basic Share | $329.4M | $417.7M | $422.7M | $426.8M | $441.1M | |
| Weighted Average Diluted Share | $329.4M | $417.7M | $422.7M | $431M | $441.1M | |
| EBITDA | -$360.2M | -$455.2M | $212.4M | $481.6M | $427M | |
| EBIT | -$544M | -$650.6M | $1.8M | $236.5M | $176.4M | |
| Revenue (Reported) | $3.1M | $521.9M | $1.8B | $2.2B | $2.1B | |
| Operating Income (Reported) | -$571.3M | -$688.8M | $10.7M | $218.4M | $200.9M | |
| Operating Income (Adjusted) | -$544M | -$650.6M | $1.8M | $236.5M | $176.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $36.1M | $1.2B | $6.1B | $8.9B | $9.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $899.7M | $2.1B | $4.8B | $5.6B | $5.6B | |
| Gross Profit | -$863.5M | -$975.8M | $1.3B | $3.3B | $3.8B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $677.9M | $984.5M | $1.4B | $1.4B | $1.5B | |
| Other Inc / (Exp) | -$12.2M | $134.8M | $29.5M | -$13.1M | $11.6M | |
| Operating Expenses | $1.4B | $1.7B | $2.2B | $2.2B | $2.4B | |
| Operating Income | -$2.2B | -$2.7B | -$852.3M | $1.1B | $1.4B | |
| Net Interest Expenses | $1.2B | $1.6B | $645.1M | $774.5M | $746.9M | |
| EBT. Incl. Unusual Items | -$3.5B | -$4.1B | -$1.5B | $351M | $713.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $20.4M | $7.9M | -$21.4M | $8.2M | -$139.5M | |
| Net Income to Company | -$3.5B | -$4.1B | -$1.4B | $342.9M | $852.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$3.5B | -$4.1B | -$1.4B | $342.9M | $852.6M | |
| Basic EPS (Cont. Ops) | -$12.16 | -$10.59 | -$3.44 | $0.80 | $1.95 | |
| Diluted EPS (Cont. Ops) | -$12.16 | -$10.59 | -$3.44 | $0.70 | $1.73 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$1.5B | -$1.8B | $2.5M | $2B | $2.4B | |
| EBIT | -$2.2B | -$2.5B | -$822.8M | $1.1B | $1.5B | |
| Revenue (Reported) | $36.1M | $1.2B | $6.1B | $8.9B | $9.4B | |
| Operating Income (Reported) | -$2.2B | -$2.7B | -$852.3M | $1.1B | $1.4B | |
| Operating Income (Adjusted) | -$2.2B | -$2.5B | -$822.8M | $1.1B | $1.5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.1M | $521.9M | $1.8B | $2.2B | $2.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $200.9M | $735.4M | $1.3B | $1.4B | $1.3B | |
| Gross Profit | -$197.8M | -$213.5M | $541.5M | $803.8M | $823.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $203.2M | $296.2M | $336M | $362.5M | $391.4M | |
| Other Inc / (Exp) | $27.2M | $38.1M | -$9M | $18.1M | -$24.5M | |
| Operating Expenses | $373.5M | $475.3M | $530.8M | $585.4M | $622.7M | |
| Operating Income | -$571.3M | -$688.8M | $10.7M | $218.4M | $200.9M | |
| Net Interest Expenses | $824.4M | $327.7M | $171.3M | $218.2M | $217.9M | |
| EBT. Incl. Unusual Items | -$1.4B | -$978.3M | -$169.5M | $18.4M | -$41.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.7M | $4.4M | -$10.2M | $1M | -$1.1M | |
| Net Income to Company | -$1.4B | -$982.7M | -$159.3M | $17.4M | -$40.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1.4B | -$982.7M | -$159.3M | $17.4M | -$40.3M | |
| Basic EPS (Cont. Ops) | -$4.16 | -$2.35 | -$0.38 | $0.04 | -$0.09 | |
| Diluted EPS (Cont. Ops) | -$4.16 | -$2.35 | -$0.38 | $0.04 | -$0.09 | |
| Weighted Average Basic Share | $329.4M | $417.7M | $422.7M | $426.8M | $441.1M | |
| Weighted Average Diluted Share | $329.4M | $417.7M | $422.7M | $431M | $441.1M | |
| EBITDA | -$360.2M | -$455.2M | $212.4M | $481.6M | $427M | |
| EBIT | -$544M | -$650.6M | $1.8M | $236.5M | $176.4M | |
| Revenue (Reported) | $3.1M | $521.9M | $1.8B | $2.2B | $2.1B | |
| Operating Income (Reported) | -$571.3M | -$688.8M | $10.7M | $218.4M | $200.9M | |
| Operating Income (Adjusted) | -$544M | -$650.6M | $1.8M | $236.5M | $176.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3.3B | $1.5B | $947M | $402.4M | $190.8M | |
| Short Term Investments | -- | $240M | -- | -- | -- | |
| Accounts Receivable, Net | $20.6M | $1.2B | $326.3M | $280.3M | $221.4M | |
| Inventory | $82.4M | $118.2M | $148.7M | $157.6M | $149.7M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $154.1M | $269.2M | $450.9M | $472.8M | $448.2M | |
| Total Current Assets | $3.6B | $3.3B | $1.9B | $1.3B | $1B | |
| Property Plant And Equipment | $13.4B | $13.5B | $14.5B | $16.4B | $16.8B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $98.1M | $98.1M | $98.1M | $98.1M | $135.8M | |
| Other Intangibles | $500.5M | $500.5M | $500.5M | $500.5M | $500.5M | |
| Other Long-Term Assets | $831.9M | $1.3B | $1.6B | $1.1B | $1.5B | |
| Total Assets | $18.4B | $18.7B | $18.6B | $19.5B | $20B | |
| Accounts Payable | $83.1M | $233.2M | $228.7M | $174.3M | $171.1M | |
| Accrued Expenses | $596.1M | $1.1B | $1.3B | $1.1B | $1.2B | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.9B | $3.7B | $5.1B | $6B | $5.8B | |
| Long-Term Debt | $11.7B | $11.6B | $12.6B | $12.3B | $11.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $14B | $16.3B | $18.5B | $19.2B | $18.5B | |
| Common Stock | $316K | $417K | $421K | $425K | $440K | |
| Other Common Equity Adj | -$240.1M | -$285.1M | -$477.1M | -$508.4M | -$507M | |
| Common Equity | $4.4B | $2.4B | $68.6M | $300.8M | $1.4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $4.4B | $2.4B | $68.6M | $300.8M | $1.4B | |
| Total Liabilities and Equity | $18.4B | $18.7B | $18.6B | $19.5B | $20B | |
| Cash and Short Terms | $3.3B | $1.7B | $947M | $402.4M | $190.8M | |
| Total Debt | $11.8B | $12.4B | $13.6B | $14.1B | $13.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3.5B | $2.1B | $700.6M | $559.8M | $184.4M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $18.6M | $545M | $259.3M | $282.3M | $270.5M | |
| Inventory | $84.7M | $142M | $145.9M | $157.9M | $155.7M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $168M | $390.8M | $538.8M | $590.1M | $534.9M | |
| Total Current Assets | $3.8B | $3.2B | $1.6B | $1.6B | $1.1B | |
| Property Plant And Equipment | $13.4B | $13.5B | $14.5B | $16.5B | $18.1B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $98.1M | $98.1M | $98.1M | $98.1M | $135.8M | |
| Other Intangibles | $500.5M | $500.5M | $500.5M | $500.5M | $500.5M | |
| Other Long-Term Assets | $1.2B | $1.9B | $1.6B | $1.2B | $1.5B | |
| Total Assets | $19B | $19.3B | $18.4B | $19.8B | $21.4B | |
| Accounts Payable | $92.7M | $91.8M | $203.2M | $205M | $161.8M | |
| Accrued Expenses | $560.2M | $1.1B | $1.1B | $1B | $1B | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.8B | $4.2B | $5.7B | $6.6B | $6.1B | |
| Long-Term Debt | $12.2B | $12.6B | $11.9B | $12B | $12.9B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $14.6B | $17.7B | $18.5B | $19.5B | $19.9B | |
| Common Stock | $370K | $419K | $424K | $429K | $443K | |
| Other Common Equity Adj | -$291.2M | -$250.8M | -$505.4M | -$464.4M | -$472.1M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $4.4B | $1.5B | -$99.5M | $362.1M | $1.4B | |
| Total Liabilities and Equity | $19B | $19.3B | $18.4B | $19.8B | $21.4B | |
| Cash and Short Terms | $3.5B | $2.1B | $700.6M | $559.8M | $184.4M | |
| Total Debt | $12.2B | $13.6B | $13.1B | $13.7B | $14B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$4B | -$4.5B | -$2.3B | $166.2M | $910.3M | |
| Depreciation & Amoritzation | $739.6M | $758.6M | $810.1M | $883.2M | $973.5M | |
| Stock-Based Compensation | $111.3M | $124.1M | $113.6M | $118.9M | $91.8M | |
| Change in Accounts Receivable | $30.8M | -$1.2B | $828.7M | $39.6M | $49.3M | |
| Change in Inventories | $10.6M | -$37.5M | -$33.6M | -$11M | $7M | |
| Cash From Operations | -$2.6B | -$2.5B | $210M | $2B | $2B | |
| Capital Expenditures | $946.5M | $752.8M | $1.8B | $2.8B | $1.2B | |
| Cash Acquisitions | -- | -- | -- | -- | -$27.3M | |
| Cash From Investing | -$975.4M | -$1B | -$1.8B | -$2.9B | -$1.2B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $6.1B | $2.6B | $3B | $4.3B | $1.3B | |
| Long-Term Debt Repaid | -$892.5M | -$2.1B | -$1.8B | -$3.8B | -$2.2B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$135.3M | -$1.5B | -$230.9M | -$196.3M | -$136.3M | |
| Cash From Financing | $6.6B | $1.7B | $986.2M | $346.9M | -$1B | |
| Beginning Cash (CF) | $252.9M | $3.3B | $1.5B | $947M | $402.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $3B | -$1.8B | -$559.7M | -$544.6M | -$211.7M | |
| Ending Cash (CF) | $3.3B | $1.5B | $947M | $402.4M | $190.8M | |
| Levered Free Cash Flow | -$3.5B | -$3.2B | -$1.6B | -$744.6M | $838.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$1.4B | -$982.7M | -$159.3M | $17.4M | -$40.3M | |
| Depreciation & Amoritzation | $183.8M | $195.5M | $210.7M | $245.1M | $250.5M | |
| Stock-Based Compensation | $26.6M | $32.8M | $28.2M | $21.9M | $20.3M | |
| Change in Accounts Receivable | -$2.6M | $618.9M | $65.4M | -$4.1M | -$50.2M | |
| Change in Inventories | -$2.4M | -$24.1M | $2.8M | -$517K | -$6.1M | |
| Cash From Operations | -$852M | -$371M | $503.3M | $807.2M | $679.2M | |
| Capital Expenditures | $136.4M | $165.3M | $237.7M | $258.9M | $1.5B | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$343.3M | $79.7M | -$236.4M | -$255.2M | -$1.5B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.2B | $2.1B | $1.3B | $92.4M | $3.7B | |
| Long-Term Debt Repaid | -$870.4M | -$935.4M | -$1.8B | -$425.3M | -$2.7B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$636.9M | -$206.8M | -$13.9M | -$39.6M | -$85.5M | |
| Cash From Financing | $1.2B | $921.5M | -$513.4M | -$394.5M | $846.6M | |
| Beginning Cash (CF) | $3.3B | $1.5B | $947M | $402.4M | $190.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.6M | $630.2M | -$246.4M | $157.4M | -$6.4M | |
| Ending Cash (CF) | $3.3B | $2.1B | $700.6M | $559.8M | $184.4M | |
| Levered Free Cash Flow | -$988.4M | -$536.3M | $265.7M | $548.3M | -$846M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$3.5B | -$4.1B | -$1.4B | $342.9M | $852.6M | |
| Depreciation & Amoritzation | $728.2M | $770.3M | $825.3M | $917.7M | $979M | |
| Stock-Based Compensation | $105.1M | $130.3M | $108.9M | $112.7M | $90.1M | |
| Change in Accounts Receivable | $51.3M | -$538.5M | $275.2M | -$29.8M | $3.1M | |
| Change in Inventories | -$1.1M | -$59.3M | -$6.7M | -$14.4M | $1.3M | |
| Cash From Operations | -$3.4B | -$2B | $1.1B | $2.3B | $1.9B | |
| Capital Expenditures | $472.7M | $781.8M | $1.9B | $2.8B | $2.5B | |
| Cash Acquisitions | -- | -- | -- | -- | -$27.3M | |
| Cash From Investing | -$680.7M | -$581.1M | -$2.1B | -$2.9B | -$2.5B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $5.2B | $3.5B | $2.3B | $3.1B | $4.9B | |
| Long-Term Debt Repaid | -$1.6B | -$2.2B | -$2.7B | -$2.4B | -$4.5B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$759.2M | -$1B | -$38M | -$222M | -$182.2M | |
| Cash From Financing | $6B | $1.4B | -$448.7M | $465.7M | $209.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.9B | -$1.2B | -$1.4B | -$140.8M | -$375.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$3.8B | -$2.8B | -$771.9M | -$462M | -$555.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$1.4B | -$982.7M | -$159.3M | $17.4M | -$40.3M | |
| Depreciation & Amoritzation | $183.8M | $195.5M | $210.7M | $245.1M | $250.5M | |
| Stock-Based Compensation | $26.6M | $32.8M | $28.2M | $21.9M | $20.3M | |
| Change in Accounts Receivable | -$2.6M | $618.9M | $65.4M | -$4.1M | -$50.2M | |
| Change in Inventories | -$2.4M | -$24.1M | $2.8M | -$517K | -$6.1M | |
| Cash From Operations | -$852M | -$371M | $503.3M | $807.2M | $679.2M | |
| Capital Expenditures | $136.4M | $165.3M | $237.7M | $258.9M | $1.5B | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$343.3M | $79.7M | -$236.4M | -$255.2M | -$1.5B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.2B | $2.1B | $1.3B | $92.4M | $3.7B | |
| Long-Term Debt Repaid | -$870.4M | -$935.4M | -$1.8B | -$425.3M | -$2.7B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$636.9M | -$206.8M | -$13.9M | -$39.6M | -$85.5M | |
| Cash From Financing | $1.2B | $921.5M | -$513.4M | -$394.5M | $846.6M | |
| Beginning Cash (CF) | $3.3B | $1.5B | $947M | $402.4M | $190.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.6M | $630.2M | -$246.4M | $157.4M | -$6.4M | |
| Ending Cash (CF) | $3.3B | $2.1B | $700.6M | $559.8M | $184.4M | |
| Levered Free Cash Flow | -$988.4M | -$536.3M | $265.7M | $548.3M | -$846M | |
Get NCLH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NCLH
Sector
P/E ratio
13.32x
16.92x
PEG ratio
0.09x
0.17x
P/B ratio
7.27x
1.42x
Price / LTM sales
1.22x
0.68x
Growth Metrics
NCLH
Sector
Revenue growth
-2.91%
0.64%
Earnings growth
33.8%
-1.02%
Revenue (5-year growth)
7.96%
3.61%
Earnings forecast
$0.51
$0.24
Profitability
NCLH
Sector
Profitability FY 2024
$3.8B
$456.7M
Return on invested capital
5.86%
4.58%
Return on assets
4.22%
2.72%
Return on equity
84.71%
6.7%
Earnings Date
Last Earnings Date
Apr
30
Next Earnings Date
Jul
31
Estimated Next Earnings Date
Jul
30
Balance Sheet
NCLH
Sector
Total cash
$184.4M
$139.6M
Short term investments
--
$46.8M
Total assets
$20B
$1.4B
Long term debt
$14B
$128.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
